¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ILO"¿¡ ´ëÇÑ ¿µ¿µ ÀÇÇлçÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
ILO <abbreviation> International Labour Organization.
(05 Mar 2000)
iloprost <chemical> A stable synthetic analog of epoprostenol but with a longer half-life than the parent compound. The drug has vasodilator and antiplatelet activities and improves the fibrinolytic activity in patients with atherosclerotic disease, thereby providing them with further antithrombotic protection. It is also used in the treatment of raynaud's disease and provides dose-dependent protection of the heart against some of the deleterious effects of ischemia and reperfusion.
Pharmacological action: platelet aggregation inhibitors, vasodilator agents.
Chemical name: Pentanoic acid, 5-(hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2(1H)-pentalenylidene)-
(12 Dec 1998)
Ilosvay Lajos de, Hungarian chemist, *1851.
See: Ilosvay reagent.
(05 Mar 2000)
Ilosvay reagent Sulfanilic acid 0.5, dissolved in dilute acetic acid 150, mixed with naphthylamine 1, and dissolved in boiling water 20; the blue sediment which forms is dissolved in dilute acetic acid 150; a few drops of this reagent added to water, saliva, or other fluid to be tested will produce a red colour if nitrites are present.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á